← Leaderboards
Katie Elizabeth Copley
University Of Pennsylvania
$130,976
Attributed
$130,976
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$130,976 · 1
By mechanism
F31$130,976 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- John Q. Trojanowski$38,320,321
- Virginia M Lee$38,958,370
- Edward Byung-Ha Lee$19,157,828
- Murray Grossman$38,029,353
- David A Wolk$32,363,067
Others in their field
Other Rising Stars on “Evolution”
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Anice Lowen · Emory University$10,193,979
- Peter N. Schmidt · Rho Federal Systems Division, Inc.$8,977,742
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Brian J Lopresti · University Of Pittsburgh At Pittsburgh$6,934,890
- Jennifer L. Kraschnewski · Pennsylvania State Univ Hershey Med Ctr$6,438,530
Research focus
EvolutionAlzheimer&AposAffectAls PatientsBehaviorBindingAmyotrophic Lateral SclerosisCareerCell ModelCellsCellular PathologyCessation Of LifeCollaborative EnvironmentCrosslinking And Immunoprecipitation SequencingC-TerminalBiochemicalData AnalysesDesignDisease PhenotypeDisorder SubtypeElectron MicroscopyEnvironmentEtiologyExhibits
Grant awards (3)
Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD$36,530
F31 · FY2024 · NS · contact PI
Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD$47,694
F31 · FY2023 · NS · contact PI
Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD$46,752
F31 · FY2022 · NS · contact PI